Balofloxacin bacterial infections in treatment of urinary system diseases multi-center randomized double-blind parallel-controlled clinical trial positive drug

                      Author: Zhang Yan Zhao Tao-you Liu Liqiu December Xuezhi water to take the Kuo Kuang-hua Dong Hua Lou
[Abstract] Objective To evaluate the efficacy and Balofloxacin tablets treatment of mild to moderate bacterial infections of urinary system diseases, the clinical efficacy and safety. Methods A multi-center, double-blind double-dummy, parallel, randomized controlled trials positive drug designed to levofloxacin as the control drug, the pilot Balofloxacin drug. Balofloxacin 100mg, 2 times a day; levofloxacin 200mg, 2 times a day course of treatment were 7 ~ 10d. The results of this study enrolled a total of 210 cases of a number of cases, Balofloxacin levofloxacin group and 105 cases of two groups, of which Balofloxacin FAS analysis of 104 cases of group, PPS analysis of 100 cases; FAS analysis of levofloxacin group of 103 cases, PPS analysis of 103 cases of . The end of treatment, FAS analysis Balofloxacin group cure rate and effective rates were 69.23% and 95.19%, levofloxacin group cure rate and effective rates were 67.96% and 97.09%; PPS analysis Balofloxacin group healing rate and effective rate was 70.00% and 97.00%, levofloxacin group cure rate and effective rates were 67.96% and 97.09%; two groups of cure rate and effective no significant statistical difference (P

RELATED TOPICS

Pharmacy Papers